Cargando…
Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer
Small cell lung cancer (SCLC) is a highly malignant tumor which is eventually refractory to any treatment. Intratumoral heterogeneity (ITH) may contribute to treatment failure. However, the extent of ITH in SCLC is still largely unknown. Here, we subject 120 tumor samples from 40 stage I-III SCLC pa...
Autores principales: | Zhou, Huaqiang, Hu, Yi, Luo, Rongzhen, Zhao, Yuanyuan, Pan, Hui, Ji, Liyan, Zhou, Ting, Zhang, Lanjun, Long, Hao, Fu, Jianhua, Wen, Zhesheng, Wang, Siyu, Wang, Xin, Lin, Peng, Yang, Haoxian, Wang, Junye, Song, Mengmeng, Yi, Xin, Yang, Ling, Xia, Xuefang, Guan, Yanfang, Fang, Wenfeng, Yang, Yunpeng, Hong, Shaodong, Huang, Yan, Li, Pansong, Zhang, Yaxiong, Zhou, Ningning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440529/ https://www.ncbi.nlm.nih.gov/pubmed/34521849 http://dx.doi.org/10.1038/s41467-021-25787-x |
Ejemplares similares
-
Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing
por: Zhang, Yaxiong, et al.
Publicado: (2019) -
Preferable background filtering for next-generation sequencing analysis in non-small cell lung cancer: pericarcinomatous tissues or peripheral blood lymphocytes?
por: Zhang, Yaxiong, et al.
Publicado: (2019) -
The correlations of tumor mutational burden among single-region tissue, multi-region tissues and blood in non-small cell lung cancer
por: Zhang, Yaxiong, et al.
Publicado: (2019) -
Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer
por: Fang, Wenfeng, et al.
Publicado: (2021) -
Analysis of genomic and immune intratumor heterogeneity in linitis plastica via multiregional exome and T‐cell receptor sequencing
por: Huang, Jin, et al.
Publicado: (2023)